Home » Newsletters » BioWorld Science

BioWorld Science

March 6, 2003

View Archived Issues

Novel antidiabetic beta3-adrenoceptor agonists covered by Wyeth patent

New inhibitors of SGLT transporters discovered by Kyowa Hakko scientists

Antiallergic peptides presented by Hayashibara and Sankyo researchers

Boehringer Ingelheim prepares and tests series of HCV NS5B inhibitors

NeoTherapeutics describes new agents for neuronal stimulation and regeneration

Novel mGluR antagonists with utility in cerebral infarction and neuropathic pain

Antibacterial quinolizinones in early development at Sato

Mercian claims HMG-CoA-inhibitory mevastatin analogues

New ascorbate-tocopherol adduct with dual activity as elastase inhibitor and free radical scavenger

Novuspharma updates R&D development and clinical progress

Reduced hyperinflammatory response reported after postinjury PolyHeme rescue

IL-2 combined with HAART reported to enhance immune restoration in HIV infection

Versicor and Biosearch Italia complete merger, summarize results for 2002

Avelox approved for CAP pneumonia due to penicillin-resistant S. pneumoniae

CG-53135 cleared to enter phase I trials

Recombinant AAT therapy enters phase I

Priority review granted for Arixtra sNDA

Myoview approved for assessment of left ventricular function

Consistent positive weight loss trends observed in AOD-9604 trial

Phase III protocol for tesmilifene accepted by FDA

New phase II study assesses NS-2330 for advanced Parkinson's disease

Ilex Campath rights broadened to all nononcology therapeutic uses

Synergistic antitumor activity for antiestrogen/FTI combinations in ER-positive breast cancer

Kyorin and Eisai to jointly market rizatriptan for migraine in Japan

BioSante completes menopause phase II/III trial of Bio-E-Gel

Calanolide A combination therapy for HIV completes clinical trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...